Sr Manager, Medical Writing in भारत

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.

Title: Sr Manager, Medical Writing

Position Summary

Kyverna is seeking an experienced Senior Manager, Medical Writer to provide regulatory medical writing support for development programs. This individual will serve as an independent contributor responsible for developing high-quality regulatory documents supporting FDA interactions and clinical development activities.

The ideal candidate brings extensive medical writing experience in Autoimmune diseases (Stiff Person Syndrome, Myasthenia Gravis, Progressive Multiple Sclerosis) and has a proven ability to independently author complex regulatory documents with minimal oversight. This role will partner closely with Clinical Development, Regulatory Affairs, Clinical Operations, and other cross-functional stakeholders to support critical regulatory milestones.

Responsibilities

• Independently author, edit, and finalize complex regulatory documents supporting clinical development programs, ensuring scientific accuracy, consistency, and compliance with regulatory requirements.
• Lead development of FDA briefing documents, including materials supporting RMAT, Breakthrough Therapy Designation, and other Agency interactions.
• Develop clinical protocol synopses and contribute to full protocol development for clinical studies.
• Collaborate with Clinical Development, Regulatory Affairs, Biostatistics, Clinical Operations, Translational Medicine, and other functional teams to gather, interpret, and synthesize scientific and clinical information.
• Drive document development timelines, proactively managing reviews, incorporating cross-functional feedback, and delivering high-quality documents on schedule.
• Ensure documents are aligned with FDA guidance, ICH guidelines, and company standards.
• Participate in document planning meetings and provide strategic input on document structure, messaging, and regulatory presentation.
• Support additional regulatory and clinical documents as business needs evolve.

Qualifications

• Advanced degree (PhD, PharmD, MD, MS, or equivalent) in Life Sciences, Pharmacy, Medicine, or a related scientific discipline preferred.
• 10+ years of medical writing experience within the biotechnology or pharmaceutical industry.
• Highly experienced medical writer with deep therapeutic expertise in multiple sclerosis, preferably progressive MS, and a demonstrated track record of independently authoring complex regulatory documents
• Extensive experience independently authoring FDA regulatory documents, including briefing packages, meeting requests, and clinical development documents.
• Proven experience developing FDA briefing documents supporting RMAT, Breakthrough Therapy Designation, or similar regulatory interactions.
• Strong experience writing clinical protocols and protocol synopses.
• Thorough understanding of FDA regulations, ICH guidelines, and GCP requirements.
• Ability to independently manage multiple projects with minimal supervision while meeting aggressive timelines.
• Exceptional scientific writing, editing, communication, and project management skills.
• Experience working in fast-paced, cross-functional clinical development environments.

The national salary range for this position is $170K to $190K USD annually.  The salary range is an estimate of what we reasonably expect to pay for this position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data.  This position is also eligible for bonus, benefits, and participation in Company’s stock plan.